Use of the human tumor stem cell assay (HTSCA) to prospectively select patients for phase I and II clinical trials of bisantrene (BIS)

D. S. Alberts, C. Mackel, S. E. Salmon

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Number of pages1
JournalStem Cells
Issue number4-5
StatePublished - Jan 1 1981

ASJC Scopus subject areas

  • Molecular Medicine
  • Developmental Biology
  • Cell Biology

Cite this